Journal of Mental Health Counseling
October 1, 2020
Russ Curtis, Lisen C. Roberts, Elizabeth Graves et al.
28 citations
Psychedelics (i.e., ketamine, methylenedioxymethamphetamine, psilocybin) have been effectively used globally for centuries to treat mental health and addiction issues. However, in the 1950s–1970s, a number of factors, including misuse, abuse, and poorly conceptualized and conducted clinical trials, caused the Federal Drug Administration to classify most of the psychedelic substances as having...
SMAD Revista Eletrônica Saúde Mental Álcool e Drogas (Edição em Português)
September 30, 2020
Nazaré de Oliveira Almeida, Marcelo Demarzo, Carmem Beatriz Neufeld
4 citations
Objetivo: estudo de casos múltiplos teve objetivo de avaliar a aplicabilidade do protocolo de grupo de um programa de 8 semanas de Terapia Cognitiva Baseada em Mindfulness adaptado para o atendimento clínico individual de pacientes com sintomas de depressão. Método: para o estudo de casos múltiplos, no qual 11 casos de pacientes com diagnósticode depressão leve à moderada submetidos à...
Psychiatric News
September 29, 2020
Nicole Harrington Cirino
1 citation
Back to table of contents Previous article Next article ViewpointsFull AccessWait for the Science Before Widespread Use of PsilocybinNicole Harrington Cirino, M.D.Nicole Harrington Cirino, M.D.Published Online:28 Sep 2020https://doi.org/10.1176/appi.pn.2020.10a32AbstractThe momentum behind psilocybin as the next big "breakthrough" in treating psychiatric disorders is strong, but Oregon...
Farmacja Polska
September 28, 2020
Agata Tadeja
1 citation
Research on using drugs in medicine was almost completely stopped and delegalized in 1971, by Convention on Psychotropic Substances. Most of studies carried out before 1971 were methodologically inappropriate according to current research methodologies, yet it was proven that there is some potential in using substances like lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine,...
Smart Biofeedback - Perspectives and Applications
September 28, 2020
Jeff Tarrant
11 citations
Beginning meditators often complain that they do not know if they are “doing it right” or give up before realizing significant benefits. Advanced meditators often reach a plateau and struggle to reach “the next level” of their practice. Modern researchers and practitioners are finding a possible new solution to these challenges by using EEG biofeedback to increase awareness of subtle states of...
Journal of Evidence-Based Integrative Medicine
September 25, 2020
Medha Kaushik, Akarshi Jain, Puneet Agarwal et al.
During recent decades, stress-related neuropsychiatric disorders such as anxiety, depression, chronic tension headache, and migraine have established their stronghold in the lives of a vast number of people worldwide. In order to address this global phenomenon, intensive studies have been carried out leading to the advancement of drugs like anti-depressants, anxiolytics, and analgesics which...
Mindfulness
September 24, 2020
S. Kriakous, K. Elliott, Carolien Lamers et al.
Burnout and occupational stress are frequently experienced by healthcare professionals (HCPs). Mindfulness-based stress reduction (MBSR) has been found to improve the psychological health outcomes of HCPs. To date, systematic reviews and meta-analyses have primarily focused upon empirical investigations into the reduction of stress amongst HCPs using MBSR and are limited to empirical studies...
EClinicalMedicine
September 24, 2020
B. Anderson, Alicia Danforth, Prof Robert Daroff et al.
271 citations
BACKGROUND: Psilocybin therapy has shown promise as a rapid-acting treatment for depression, anxiety, and demoralization in patients with serious medical illness (e.g., cancer) when paired with individual psychotherapy. This study assessed the safety and feasibility of psilocybin-assisted group therapy for demoralization in older long-term AIDS survivor (OLTAS) men, a population with a high...
Pharmacology, Biochemistry, and Behavior
September 22, 2020
Kennett D. Radford, Rina Y. Berman, Michael Zhang et al.
Ketamine, a multimodal dissociative anesthetic drug, is widely used to treat various conditions including acute pain and treatment-resistant depression. We previously reported that subanesthetic doses of intravenous (i.v.) ketamine produced transient dissociative stereotypy and antinociception in male rats. However, sex-related differences in the effects of i.v. ketamine on these measures are...
Trials
September 22, 2020
Gladys E Ibañez, Kristopher Fennie, Linda Larkey et al.
Background: Almost half of people living with HIV (PLWH) in the USA are over 50 years of age; this is expected to increase to 70% by 2020. Yet, few interventions exist for older PLWH that address psychological and physical symptoms combined, both prevalent in this population. There is a need to find innovative and accessible interventions that can help older PLWH to manage their symptoms....